Alto Neuroscience, Inc.'s total assets for Q3 2024 were $191.61M, a decrease of -2.91% from the previous quarter. ANRO total liabilities were $26.56M for the fiscal quarter, a 51.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.